Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Cancer Cell|April 17, 2026
Identification of cycling regulatory T cell precursors as conductors of immune escape during breast carcinoma progressionTriet Minh Bui, Ernesto Rojas Jimenez, Zheqi Li, et al.
Nature Immunology|June 5, 2019
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppressionQingsong Hu, Youqiong Ye, Li-Chuan Chan, et al.
Cancer Cell|November 18, 2022
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohortsSiri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, et al.
Nature Genetics|June 10, 2022
Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancerEsther H Lips, Tapsi Kumar, Anargyros Megalios, et al.
Cancer Research|March 12, 2009
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancerJoellen M Schildkraut, Ellen L Goode, Merlise A Clyde, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 2010
Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association ConsortiumCatherine M Phelan, Ya-Yu Tsai, Ellen L Goode, et al.
Carcinogenesis|October 2, 2015
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancerKate Lawrenson, Edwin S Iversen, Jonathan Tyrer, et al.
American Journal of Human Genetics|May 9, 2024
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regionsEileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Pageof 15